Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 14 studies | 28% ± 12% | |
| macrophage | 14 studies | 26% ± 12% | |
| monocyte | 7 studies | 21% ± 9% | |
| myeloid cell | 7 studies | 24% ± 8% | |
| adipocyte | 7 studies | 32% ± 12% | |
| astrocyte | 6 studies | 35% ± 10% | |
| Mueller cell | 6 studies | 52% ± 18% | |
| neutrophil | 5 studies | 35% ± 19% | |
| microglial cell | 5 studies | 25% ± 6% | |
| platelet | 5 studies | 23% ± 7% | |
| oligodendrocyte precursor cell | 5 studies | 29% ± 12% | |
| non-classical monocyte | 4 studies | 28% ± 8% | |
| epithelial cell | 4 studies | 36% ± 10% | |
| basal cell | 4 studies | 30% ± 12% | |
| hematopoietic precursor cell | 3 studies | 33% ± 20% | |
| megakaryocyte | 3 studies | 24% ± 7% | |
| abnormal cell | 3 studies | 29% ± 11% | |
| hepatocyte | 3 studies | 40% ± 17% | |
| hematopoietic stem cell | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 6163.58 | 226 / 226 | 95% | 71.30 | 386 / 406 |
| uterus | 100% | 3156.69 | 170 / 170 | 93% | 84.61 | 426 / 459 |
| breast | 100% | 4813.31 | 459 / 459 | 86% | 47.51 | 965 / 1118 |
| skin | 100% | 3943.66 | 1804 / 1809 | 86% | 165.30 | 407 / 472 |
| lung | 100% | 3593.53 | 576 / 578 | 85% | 47.86 | 979 / 1155 |
| ovary | 100% | 2314.34 | 180 / 180 | 78% | 23.26 | 336 / 430 |
| bladder | 90% | 3962.38 | 19 / 21 | 88% | 71.90 | 441 / 504 |
| esophagus | 89% | 3241.03 | 1279 / 1445 | 73% | 53.25 | 134 / 183 |
| intestine | 91% | 2045.40 | 877 / 966 | 65% | 23.73 | 340 / 527 |
| prostate | 98% | 1786.72 | 240 / 245 | 51% | 12.45 | 258 / 502 |
| kidney | 65% | 1032.96 | 58 / 89 | 83% | 37.67 | 750 / 901 |
| thymus | 94% | 1433.93 | 613 / 653 | 47% | 9.66 | 285 / 605 |
| adrenal gland | 97% | 2693.23 | 249 / 258 | 9% | 2.88 | 20 / 230 |
| adipose | 100% | 7590.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 99% | 6411.80 | 239 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 284.57 | 79 / 80 |
| blood vessel | 98% | 2255.30 | 1307 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 52% | 871.52 | 185 / 359 | 46% | 14.27 | 131 / 286 |
| pancreas | 11% | 124.15 | 36 / 328 | 83% | 32.81 | 148 / 178 |
| brain | 28% | 412.07 | 729 / 2642 | 62% | 25.70 | 435 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 65.25 | 39 / 45 |
| peripheral blood | 82% | 29279.02 | 759 / 929 | 0% | 0 | 0 / 0 |
| heart | 50% | 796.17 | 429 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 4.69 | 6 / 29 |
| muscle | 10% | 124.95 | 83 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005977 | Biological process | glycogen metabolic process |
| GO_0009617 | Biological process | response to bacterium |
| GO_0006015 | Biological process | 5-phosphoribose 1-diphosphate biosynthetic process |
| GO_0005980 | Biological process | glycogen catabolic process |
| GO_0070266 | Biological process | necroptotic process |
| GO_0042593 | Biological process | glucose homeostasis |
| GO_0005576 | Cellular component | extracellular region |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0034774 | Cellular component | secretory granule lumen |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008184 | Molecular function | glycogen phosphorylase activity |
| GO_0019842 | Molecular function | vitamin binding |
| GO_0030170 | Molecular function | pyridoxal phosphate binding |
| GO_0102250 | Molecular function | linear malto-oligosaccharide phosphorylase activity |
| GO_0102499 | Molecular function | SHG alpha-glucan phosphorylase activity |
| GO_0016208 | Molecular function | AMP binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0032052 | Molecular function | bile acid binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005536 | Molecular function | D-glucose binding |
| GO_0002060 | Molecular function | purine nucleobase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PYGL |
| Protein name | Glycogen phosphorylase, liver form (EC 2.4.1.1) Alpha-1,4 glucan phosphorylase (EC 2.4.1.1) |
| Synonyms | |
| Description | FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . FUNCTION: Allosteric enzyme that catalyzes the rate-limiting step in glycogen catabolism, the phosphorolytic cleavage of glycogen to produce glucose-1-phosphate, and plays a central role in maintaining cellular and organismal glucose homeostasis. . |
| Accessions | ENST00000544180.6 [P06737-2] ENST00000532462.5 Q6P1L4 P06737 ENST00000216392.8 [P06737-1] E9PK47 |